Cargando…
Replicating viral vectors for cancer therapy: strategies to synergize with host immune responses
Tumour‐specific replicating (oncolytic) viruses are novel anticancer agents, currently under intense investigation in preclinical studies and phase I–III clinical trials. Until recently, most studies have focused on the direct antitumour properties of these viruses. There is now an increasing body o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815785/ https://www.ncbi.nlm.nih.gov/pubmed/21923638 http://dx.doi.org/10.1111/j.1751-7915.2011.00296.x |